Drugs Made In America Acquisition Corp. (DMAA) bonds
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)
Close on Nov 17, 2026Market cap $264.62MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Drugs Made In America Acquisition reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Drugs Made In America Acquisition's 10-Q for the period ended Mar 23, 2026
| Issue | Amount issued |
|---|---|
| Interim Loan Convertible | $100.00K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| Promissory Note {Member] | – | $0 |
See a number that looks wrong?